Nocturnal cerebral hypoxia in obstructive sleep apnoea: A randomised controlled trial
European Respiratory Journal May 03, 2018
Schwarz EI, et al. - Whether obstructive sleep apnoea (OSA) patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP), was investigated. A 2-week intervention was carried out wherein OSA patients were randomly allocated to either subtherapeutic or therapeutic CPAP. Changes in oxygenation at end of the 2-week intervention were compared between groups. OSA recurrence occurred in all 9 using subtherapeutic and in 0 using therapeutic CPAP among 21 patients (mean apnoea/hypopnoea-index 50.3/h). Findings suggested a role of cerebral hypoxia in predisposing untreated OSA patients to cerebral damage as nocturnal cerebral deoxygenation attributed to CPAP-withdrawal was evident in OSA patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries